CEMEX recognised in Fortune's 'Change the World' list

Building materials provider CEMEX has been included in the "FORTUNE 2020 Change the World" list for the third time.
Concrete Plants, Equipment & Applications / September 25, 2020
By Liam McLoughlin
CEMEX was the only construction materials company featured on the Fortune list
CEMEX was the only construction materials company featured on the Fortune list

CEMEX has previously featured in the 2015 and 2017 editions of the annual list, which highlights companies around the world that have generated a social impact through activities that are part of their business strategy.

In the 2020 list FORTUNE has recognised CEMEX's efforts in social impact business models. One of the recognised initiatives was the rapid deployment of solutions to meet the current challenges caused by the COVID-19 pandemic. Working with the Mexican Institute of Social Security and in coordination with more than 20 multisectoral partners in Mexico, CEMEX built mobile hospitals with highly durable precast antibacterial concrete modules in a record time of two weeks per medical facility.

This effort in Mexico will be replicated in other countries where CEMEX has operations to contribute to global challenges positively.

CEMEX CEO Fernando González commented: "By living our purpose of building a better future and working with our stakeholders, we seek to develop innovative solutions, while promoting a sustainable and resilient future."

FORTUNE looks for companies with recent impact to include in its annual list. It is intended to showcase capitalism's power to improve the human condition by identifying companies that have made an important social or environmental impact through their profit-making strategy and operations. Four criteria are used to select companies: measurable social impact, business results, degree of innovation, and corporate integration.

The number one position in the 2020 list was awarded collectively to "The Vaccine Makers" in the global pharmaceutical industry who between them have 200 possible COVID-19 vaccines in development, with 39 in human clinical trials.

Companies in this article